Description of Business and Summary of Significant Accounting Policies (Details Narrative) (Mymd Pharmaceuticals Inc.) - USD ($) |
1 Months Ended | 12 Months Ended | |
|---|---|---|---|
Nov. 30, 2020 |
Dec. 31, 2020 |
Dec. 31, 2019 |
|
| Ownership Percentage | 20.00% | ||
| Mymd Pharmaceuticals Inc. [Member] | |||
| Ownership Percentage | 80.00% | ||
| Impairment of intangible assets | |||
| Mymd Pharmaceuticals Inc. [Member] | Asset Purchase Agreement [Member] | |||
| Number of shares issued during period, purchase of assets | 33,937,909 | ||
| X | ||||||||||
- Definition The percentage of ownership of common stock or equity participation in the investee accounted for under the equity method of accounting. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition The amount of impairment loss recognized in the period resulting from the write-down of the carrying amount of a finite-lived intangible asset to fair value. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Definition Number of shares of stock issued during the period as part of a transaction to acquire assets that do not qualify as a business combination. No definition available.
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|